Analyst Ratings for Blueprint Medicines (BPMC)
BPMC Rating Summary
BPMC Price Target Summary
- Highest: $125.00 (H.C. Wainwright)
- Lowest: $43.00 (Leerink Partners)
- Average: $85.71
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$85.71 (-7.1%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
Avg. $ Target:
$85.71 (-7.1%)
* Over Last 12-Mos
Rating Score: 7.5 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/27/2023 | Oppenheimer » Updated 1/31/2024 |
Matthew Biegler | Upgrade | Outperform (Perform) |
90.00 (85.00) |
55.22 (92.26) |
67.08% | Details |
| 7/31/2023 | Wells Fargo » Updated 12/19/2023 |
Derek Archila | Upgrade | Overweight (Equal Weight) |
115.00 (86.00) |
63.12 (92.26) |
46.17% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
